Prognostic factors for overall survival in clinical node‐positive patients with upper tract urothelial carcinoma

Taishiro Sasahara,Takafumi Yanagisawa,Shingo Sugaya,Akira Hisakane,Keigo Sakanaka,Shuhei Hara,Takashi Otsuka,Shigeaki Takamizawa,Yuji Yata,Yusuke Takahashi,Yuki Takiguchi,Keiichiro Mori,Shunsuke Tsuzuki,Shoji Kimura,Jun Miki,Takahiro Kimura
DOI: https://doi.org/10.1111/iju.15380
2024-01-04
International Journal of Urology
Abstract:Background There is sparse evidence regarding optimal management and prognosticators for oncologic outcomes in patients with clinical node‐positive (cN+) upper tract urothelial carcinoma (UTUC). Methods We retrospectively analyzed the data from 105 UTUC patients with cN1‐2M0 between June 2010 and June 2022 at multiple institutions affiliated with our university. At the time of diagnosis, all patients received standard‐of‐care treatment including radical nephroureterectomy (RNU), chemotherapy, and/or palliative care. We employed a Cox regression model to analyze the prognostic importance of various factors on overall survival (OS). Results Of 105 patients, 54 (51%) underwent RNU, while 51 (49%) did not. RNU was likely to be selected in patients with younger and higher G8 score, resulting in better median OS in patients who underwent RNU than in those who did not (42 months vs. 15 months, p
urology & nephrology
What problem does this paper attempt to address?